EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)

15.61
Delayed Data
As of Dec 02
 +0.10 / +0.64%
Today’s Change
4.00
Today|||52-Week Range
21.50
+137.23%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 75.00 and a low estimate of 24.00. The median estimate represents a +98.59% increase from the last price of 15.61.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in EyePoint Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.52
Sales
$9.8M
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.34%
 
 
 
 
 
 
Growthannually 45.08%
 
 
 
 
 
 

Sales

Growthquarterly 7.60%
 
 
 
 
 
 
Growthannually 2.18%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.